These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 4999839)
41. [Cancer therapy using particle radiation]. Tsunemoto H Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):394-401. PubMed ID: 6309087 [TBL] [Abstract][Full Text] [Related]
42. [Medical adaptation, protection and biological gaging of a betatron of 31 MeV]. JOYET G; SCHINZ HR Schweiz Med Wochenschr; 1952 Aug; 82(34):. PubMed ID: 12994804 [No Abstract] [Full Text] [Related]
43. Clinical parameters of high energy linear accelerators. Richter CW Mo Med; 1974 Dec; 71(12):688-9. PubMed ID: 4215950 [No Abstract] [Full Text] [Related]
44. Activation processes in a medical linear accelerator and spatial distribution of activation products. Fischer HW; Tabot BE; Poppe B Phys Med Biol; 2006 Dec; 51(24):N461-6. PubMed ID: 17148816 [TBL] [Abstract][Full Text] [Related]
45. Multileaf shielding design against neutrons produced by medical linear accelerators. Rebello WF; Silva AX; Facure A Radiat Prot Dosimetry; 2008; 128(2):227-33. PubMed ID: 17569690 [TBL] [Abstract][Full Text] [Related]
46. [Formation of dose distributions in the combined radiation treatment of patients with endometrial cancer]. Kachaturian RE; Gabelov AA; Vatnitskiĭ SM Med Radiol (Mosk); 1983 Mar; 28(3):22-5. PubMed ID: 6403799 [TBL] [Abstract][Full Text] [Related]
47. Use factors for medical linear accelerators. Cobb PD; Bjärngard BE Health Phys; 1976 Nov; 31(5):463-5. PubMed ID: 826509 [No Abstract] [Full Text] [Related]
48. [The status of the upper respiratory tract and function of the olfactory analyzer in personnel working with nuclear accelerators]. Ostapkovich VE Klin Med (Mosk); 1969 Feb; 47(2):112-4. PubMed ID: 5379247 [No Abstract] [Full Text] [Related]
49. A radiation area safety interlock system for a 3-MeV accelerator. Hummer GJ Health Phys; 1971 Sep; 21(3):453-6. PubMed ID: 5095646 [No Abstract] [Full Text] [Related]
50. [Results of the treatment of small-cell undifferentiated bronchial carcinoma with combination radio and chemotherapy]. Tjho ET; Keilholz A; Broks PC Ned Tijdschr Geneeskd; 1980 Apr; 124(15):540-4. PubMed ID: 6246455 [No Abstract] [Full Text] [Related]
51. [Irradiation planning in the electron therapy of bronchial carcinoma]. Heuss K Strahlentherapie; 1971; 141(1):25-31. PubMed ID: 5002889 [No Abstract] [Full Text] [Related]
52. Kerma transmission through various materials for a p(66)Be(49) neutron beam. Awschalom M; Hrejsa A; Rosenberg I; Ten Haken RK Health Phys; 1981 Jul; 41(1):184-7. PubMed ID: 6792108 [No Abstract] [Full Text] [Related]
53. Quality assurance in radiation therapy: clinical and physical aspects. Teletherapy equipment and simulators. de Almeida CE; Cecatti ER Int J Radiat Oncol Biol Phys; 1984 Jun; 10 Suppl 1():99-103. PubMed ID: 6429105 [TBL] [Abstract][Full Text] [Related]
54. [The betatron: a new and powerful instrument given to medicine by nuclear physics]. BELLION B Minerva Med; 1952 Jul; 43(55-56):75-7. PubMed ID: 12992753 [No Abstract] [Full Text] [Related]
55. Population exposure from high-energy accelerators. Stephens LD; Thomas RH; Thomas SB Health Phys; 1975 Dec; 29(6):853-60. PubMed ID: 1201952 [No Abstract] [Full Text] [Related]
56. Monte Carlo simulations of a nozzle for the treatment of ocular tumours with high-energy proton beams. Newhauser W; Koch N; Hummel S; Ziegler M; Titt U Phys Med Biol; 2005 Nov; 50(22):5229-49. PubMed ID: 16264250 [TBL] [Abstract][Full Text] [Related]
57. [MEDICAL USE OF THE BETATRON]. MURAKAMI K Fukuoka Igaku Zasshi; 1964 Mar; 55():157-66. PubMed ID: 14165105 [No Abstract] [Full Text] [Related]
58. An approximate relation for the prediction of the dose rate from radioactivity induced in high energy particle accelerators. Sullivan AH Health Phys; 1972 Aug; 23(2):253-5. PubMed ID: 4644596 [No Abstract] [Full Text] [Related]